Angelalign Technology Inc. Stock

Equities

6699

KYG0405D1051

Medical Equipment, Supplies & Distribution

Market Closed - Hong Kong S.E. 04:08:17 2024-05-17 am EDT 5-day change 1st Jan Change
76.3 HKD +1.13% Intraday chart for Angelalign Technology Inc. +1.06% +34.92%
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Hours!
Take advantage of the offer
* See conditions on site

Financials

Sales 2024 * 1.73B 240M 1.87B Sales 2025 * 2.13B 294M 2.3B Capitalization 11.81B 1.63B 12.76B
Net income 2024 * 72M 9.96M 77.74M Net income 2025 * 165M 22.83M 178M EV / Sales 2024 * 5.24 x
Net cash position 2024 * 2.72B 376M 2.94B Net cash position 2025 * 3.23B 447M 3.49B EV / Sales 2025 * 4.04 x
P/E ratio 2024 *
159 x
P/E ratio 2025 *
69.9 x
Employees 2,883
Yield 2024 *
1.12%
Yield 2025 *
1.3%
Free-Float 21.46%
More Fundamentals * Assessed data
Dynamic Chart
Angel Aligner Accelerates Expansion with Enhanced Features and a Canadian Launch CI
Angelalign Technology Inc. Launches in Canada with Innovative Aligner Technology Built on 20+ Years of Experience and 1+ Million Smiles CI
Angelalign Technology Grants Shares to Employees MT
Angelalign Technology's 2023 Profit Plunges on Higher Costs, Misses EPS Estimates MT
Angelalign Technology Inc. Proposes Special Final Dividend for the Year Ended 31 December 2023, Payable on 24 June 2024 CI
Angelalign Technology Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Nomura Adjusts Angelalign Technology’s Price Target to HK$62.84 From HK$61.39, Keeps at Neutral. MT
Angelalign Unaware of Reason For Recent Decline in Stock Price; to Double Share Buyback MT
Angelalign Technology Inc. and Medit Corporation Unveil Seamless Software Integration, Providing Ease, Flexibility and Versatility CI
Angelalign Technology Unit Extends Supply Deal with Shanghai CareCapital Dental MT
Angelalign Technology Boosts Capital Contribution in Digital Orthodontic Partnership MT
Nomura Adjusts Angelalign Technology's Price Target to HK$61.39 From HK$126.29, Keeps at Neutral MT
Angelalign Technology Inc. Announces Executive Changes, Effective September 1, 2023 CI
Angelalign Technology Inc. Reports Earnings Results for the Half Year Ended June 30, 2023 CI
Angelalign Technology Inc. Launches Game-Changing Clear Aligner Technology in U.S. Markets CI
More news
1 day+1.13%
1 week+1.06%
Current month-3.42%
1 month-0.91%
3 months+35.28%
6 months+22.18%
Current year+34.92%
More quotes
1 week
73.50
Extreme 73.5
77.50
1 month
69.85
Extreme 69.85
82.80
Current year
45.10
Extreme 45.1
82.80
1 year
43.70
Extreme 43.7
87.25
3 years
43.70
Extreme 43.7
490.00
5 years
43.70
Extreme 43.7
490.00
10 years
43.70
Extreme 43.7
490.00
More quotes
Managers TitleAgeSince
Chief Executive Officer 50 20-12-20
Director of Finance/CFO 54 21-05-19
Chief Operating Officer 36 11-07-31
Members of the board TitleAgeSince
Chairman 48 18-11-28
Director/Board Member 69 21-04-30
Director/Board Member 47 23-04-10
More insiders
Date Price Change Volume
24-05-17 76.3 +1.13% 590 600
24-05-16 75.45 -0.46% 498,430
24-05-14 75.8 -0.66% 463,600
24-05-13 76.3 +1.06% 373,400
24-05-10 75.5 -4.25% 521,110

Delayed Quote Hong Kong S.E., May 17, 2024 at 04:08 am EDT

More quotes
ANGELALIGN TECHNOLOGY Inc is a clear aligner dental treatment solution provider. The Company provides dental professionals with self-developed digital orthodontics solutions. The Company’s Angelalign clear aligner system facilitate dental professionals throughout the entire clear aligner treatment process, include digitally-assisted case assessment support and treatment planning services, provide dental professionals with digitally-assisted case assessment support and treatment planning services, help dental professionals design, review and modify treatment plans; customized, removable clear aligners based on specific treatment plans, is a removable, transparent, plastic form of dental braces used to treat malocclusion; and cloud-based service platform, iOrtho, helps to placing orders, reviewing, modifying and finalizing their treatment plans online with the help from its medical designers, and reviewing, editing and managing medical records of their patients.
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
D-
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
10
Last Close Price
75.45 HKD
Average target price
84.59 HKD
Spread / Average Target
+12.11%
Consensus
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW